Early studies suggest Pfizer/BioNTech vaccine is effective against South African strain
BioPharma Reporter
JANUARY 28, 2021
In vitro studies found the Pfizer/BioNTech COVID-19 vaccine elicits antibodies against both the UK and South African virus strains.
Let's personalize your content